Forthun RB
ORCID: 0009-0005-7358-2616
· 1 paper in corpus
2019
PurposeValproic acid (VPA) is suggested to be therapeutically beneficial in combination with interferon-alpha (IFNα) in various cancers. Therefore, we examined IFNα and VPA alone and in combinations in selected AML models, examining immune …